Topadur Pharma AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.topadur.com
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Phase 2
Recruiting
- Conditions
- Digital Ulcers in Systemic Sclerosis
- Interventions
- First Posted Date
- 2025-05-01
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Topadur Pharma AG
- Target Recruit Count
- 15
- Registration Number
- NCT06954597
- Locations
- 🇫🇷
CHU Grenoble Alpes, La Tronche, France
🇫🇷AP-HP Hôpital Cochin, Paris, France
© Copyright 2025. All Rights Reserved by MedPath